合計 50 件の最近のインサイダー取引記録が記録されています ESSA Pharma Inc. (EPIX), 内訳は 18 件の買い および 31 件の売り. インサイダー買い総額は $11.57M インサイダー売り総額は $10.93M.
最近活動のある主要インサイダーには Biotech Growth N V, Virsik Peter, Glickman Richard M. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — EPIX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-11-01 |
Biotech Growth N V |
10 Percent Owner |
情報に基づく売り |
1,879,583 |
$1.51 |
$2.84M |
- |
| 2024-09-09 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
694 |
$6.00 |
$4.16K |
8,470 |
| 2024-09-03 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
2,082 |
$6.03 |
$12.55K |
9,164 |
| 2024-05-06 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
694 |
$6.95 |
$4.82K |
11,246 |
| 2024-04-24 |
Glickman Richard M |
Director |
オプション行使（売却） |
3,750 |
$4.90 |
$18.38K |
- |
| 2024-04-05 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
694 |
$7.94 |
$5.51K |
11,940 |
| 2024-03-25 |
Zweifach Sanford S |
Director |
RSU 付与（制限付株式） |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Berger Franklin M |
Director |
RSU 付与（制限付株式） |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Glickman Richard M |
Director |
RSU 付与（制限付株式） |
70,000 |
$9.04 |
$632.8K |
70,000 |
| 2024-03-25 |
Parkinson David Ross |
Chief Executive Officer |
RSU 付与（制限付株式） |
350,000 |
$9.04 |
$3.16M |
350,000 |
| 2024-03-25 |
Martin John Alexander |
Director |
RSU 付与（制限付株式） |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Requadt Scott |
Director |
RSU 付与（制限付株式） |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Virsik Peter |
Chief Operating Officer |
RSU 付与（制限付株式） |
110,000 |
$9.04 |
$994.4K |
110,000 |
| 2024-03-25 |
Thorell Marella |
Director |
RSU 付与（制限付株式） |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Sollis Gary |
Director |
RSU 付与（制限付株式） |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-25 |
Wood David S. |
Chief Financial Officer |
RSU 付与（制限付株式） |
110,000 |
$9.04 |
$994.4K |
110,000 |
| 2024-03-25 |
Cesano Alessandra |
Chief Medical Officer |
RSU 付与（制限付株式） |
200,000 |
$9.04 |
$1.81M |
200,000 |
| 2024-03-25 |
Merendino Lauren |
Director |
RSU 付与（制限付株式） |
25,000 |
$9.04 |
$226K |
25,000 |
| 2024-03-25 |
Kantoff Philip W. |
Director |
RSU 付与（制限付株式） |
50,000 |
$9.04 |
$452K |
50,000 |
| 2024-03-05 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
694 |
$8.98 |
$6.23K |
12,634 |
| 2024-02-06 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
72,782 |
$10.29 |
$748.93K |
13,328 |
| 2024-02-05 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
500 |
$10.04 |
$5.02K |
13,328 |
| 2024-01-16 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
1,718 |
$10.01 |
$17.2K |
14,022 |
| 2024-01-05 |
Virsik Peter |
Chief Operating Officer |
情報に基づく売り |
699 |
$6.11 |
$4.27K |
14,022 |
| 2023-12-14 |
Parkinson David Ross |
Chief Executive Officer |
情報に基づく買い |
9,223 |
$2.30 |
$21.21K |
65,675 |
| 2023-11-21 |
Berger Franklin M |
Director |
情報に基づく買い |
23,259 |
$5.73 |
$133.27K |
784,404 |
| 2023-11-07 |
Parkinson David Ross |
Chief Executive Officer |
処分 |
171,470 |
$3.23 |
$553.85K |
- |
| 2023-11-07 |
Virsik Peter |
Chief Operating Officer |
処分 |
970,000 |
$3.23 |
$3.13M |
- |
| 2023-11-07 |
Wood David S. |
Chief Financial Officer |
処分 |
330,000 |
$3.23 |
$1.07M |
- |
| 2023-11-07 |
Cesano Alessandra |
Chief Medical Officer |
処分 |
400,000 |
$3.23 |
$1.29M |
- |
| 2023-11-06 |
Requadt Scott |
Director |
その他（売り） |
12,500 |
- |
- |
30,002 |
| 2023-11-04 |
Berger Franklin M |
Director |
処分 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Glickman Richard M |
Director |
処分 |
30,000 |
$3.23 |
$96.9K |
- |
| 2023-11-04 |
Clarus Lifesciences Iii, L.p. |
10 Percent Owner |
不明 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Requadt Scott |
Director |
処分 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Brettman Ari David |
Director |
処分 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Thorell Marella |
Director |
処分 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Sollis Gary |
Director |
処分 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Zweifach Sanford S |
Director |
処分 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-04 |
Martin John Alexander |
Director |
処分 |
25,000 |
$3.23 |
$80.75K |
- |
| 2023-11-03 |
Berger Franklin M |
Director |
情報に基づく買い |
16,471 |
$5.99 |
$98.66K |
760,875 |
| 2023-11-02 |
Berger Franklin M |
Director |
情報に基づく買い |
60,000 |
$5.35 |
$321K |
744,404 |
| 2023-10-30 |
Requadt Scott |
Director |
その他（売り） |
17,502 |
- |
- |
42,502 |
| 2023-10-24 |
Wood David S. |
Chief Financial Officer |
RSU 付与（制限付株式） |
3,750 |
$3.91 |
$14.66K |
3,750 |
| 2023-06-06 |
Merendino Lauren |
Director |
処分 |
50,000 |
$3.05 |
$152.5K |
- |
| 2023-03-08 |
Berger Franklin M |
Director |
処分 |
5,000 |
$3.81 |
$19.05K |
- |
| 2023-03-08 |
Glickman Richard M |
Director |
処分 |
10,000 |
$3.81 |
$38.1K |
- |
| 2023-03-08 |
Parkinson David Ross |
Chief Executive Officer |
処分 |
45,000 |
$3.81 |
$171.45K |
- |
| 2023-03-08 |
Requadt Scott |
Director |
処分 |
5,000 |
$3.81 |
$19.05K |
- |
| 2023-03-08 |
Virsik Peter |
Chief Operating Officer |
処分 |
40,000 |
$3.81 |
$152.4K |
- |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
